Lineage tracing Endocrine progenitor
Introduction
Recent advances in experimental techniques allow for more precise control over gene expression revealing that temporal regulation of specific transcription factors is crucial to allocating the correct number of pancreatic progenitor cells to specific pancreatic lineages (Hale et al., 2005; Harmon et al., 2004; Johansson et al., 2007; Schwitzgebel et al., 2000) . Understanding the temporal and spatial regulation of these transcription factors is crucial to delineating the molecular mechanisms controlling pancreatic lineage allocation and organogenesis.
The exocrine pancreas, which produces and transports digestive enzymes to the rostral duodenum, is composed of acinar and ductal epithelial cells and accounts for $98% of adult pancreatic mass. The endocrine pancreas occupies the remaining 2% of pancreatic mass, and is subdivided into five hormone-producing cell types: glucagon-secreting a cells, insulin-secreting b cells, somatostatin-secreting d cells, pancreatic polypeptide-secreting PP cells, and ghrelin-secreting e cells (Prado et al., 2004) . Endocrine differentiation occurs in two waves: primary transition (pre-e13.5) insulin-expressing and glucagon-expressing cells are not thought to contribute to mature islets, while endocrine cells differentiating during the secondary transition (e13.5-e16.5) will give rise to mature islets (Jensen, 2004; Pictet et al., 1972) .
The Hepatic Nuclear Factor 6 (HNF6) homeodomain-containing transcription factor is an important regulator of endocrine development. HNF6 was first identified in the liver, and 75% of animals with a global HNF6 deletion (HNF6 À/À ) die within the first 10 days after birth due to liver defects (Jacquemin et al., 2000) . HNF6 is expressed early in pancreatogenesis in all endodermally-derived cells, but is not detected in differentiated endocrine cells at late-gestation (Landry et al., 1997; Rausa et al., 1997) . HNF6 null embryos show impaired endocrine differentiation and perturbed duct morphogenesis during embryogenesis (Jacquemin et al., 2000; Pierreux et al., 2006) . HNF6 acts upstream of the critical pancreatic and b cell transcription factor, pancreas/duodenum homeobox-1 (Pdx1) (Jacquemin et al., 2003) and activates expression of the proendocrine gene Neurogenin 3 (Ngn3) (Jacquemin et al., 2000) . Ngn3 is the earliest known marker of specified endocrine cells Jensen et al., 2000; Schwitzgebel et al., 2000) . Global deletion of HNF6 causes a dramatic down-regulation in Ngn3 expression, and a concomitant decrease in endocrine cells (Jacquemin et al., 2000) , while over-expression of HNF6 specifically in the endocrine lineage results in an increase in NGN3-positive cells (Wilding Crawford et al., 2008) . Mice null for Ngn3 also lack hormone-expressing cells , and lineage tracing experiments have shown that all islet endocrine cells are derived from a Ngn3-expressing progenitor (Gu et al., 2002; Schonhoff et al., 2004) . Transgenic expression of Ngn3 demonstrates that it is sufficient to direct pancreatic progenitors to all endocrine cell types (Johansson et al., 2007) .
In this study, we generated mice in which HNF6 is inactivated throughout the pdx1 domain (HNF6
Dpanc
) to further characterize the specific roles of HNF6 in pancreas development and postnatal pancreas function. Similar endocrine defects to those described in the global HNF6 null animals (Jacquemin et al., 2000) were observed in HNF6 Dpanc animals. To determine whether HNF6 plays additional roles in endocrine differentiation subsequent to Ngn3 activation, we first clarified the expression of HNF6 protein within the developing pancreas. Based on its lack of expression even in early hormone-positive cells, we hypothesized that HNF6 is required only to initiate endocrine specification. To test this hypothesis, HNF6 was inactivated specifically in cells that activated Ngn3 (HNF6
Dendo
). Loss of HNF6 from Ngn3-expressing cells did not affect b cell function or glucose homeostasis suggesting that HNF6 is dispensable for later events of endocrine differentiation. Lineage tracing analyses revealed, however, that a subset of Ngn3-expressing cells that lost HNF6 became incorporated into exocrine tissue thereby indicating that activation of Ngn3 does not irreversibly commit a cell to the endocrine lineage. HNF6 may then function to allow Ngn3 to reach a level within the pro-endocrine compartment that ensures faithful commitment of cells to the endocrine lineage.
In addition to defects in endocrine development, HNF6
Dpanc embryos showed defects in duct development similar to those observed in HNF6 À/À embryos (Pierreux et al., 2006) . HNF6
Dpanc animals all survived past weaning, allowing us to determine the consequences of HNF6 inactivation in the ductal epithelium. HNF6 Dpanc adult pancreata displayed morphological changes consistent with pancreatitis, an inflammatory process in which pancreatic enzymes autodigest the pancreas. Several molecular markers of pancreatitis, including connective tissue growth factor (CTGF), metalloproteinase-7 (MMP7), and p8/Nupr1 were elevated in HNF6 Dpanc mice. Moreover, these mice exhibited defects in primary cilia of pancreatic epithelial cells, a finding previously associated with increased cyst formation, pancreatitis, and ductal epithelial proliferation (Cano et al., 2006; Pugacheva et al., 2007) . Pancreatitis significantly elevates the risk of pancreatic cancer in humans (Lowenfels et al., 1993) , and indeed, we observed preneoplastic lesions in HNF6 Dpanc pancreata including squamous cell metaplasia and acinar-to-ductal metaplasia.
Results

2.1.
HNF6 is rapidly down-regulated as pancreatic progenitors are specified to the endocrine lineage
To determine the function of HNF6 in pancreas development subsequent to specification and early bud outgrowth, HNF6 was inactivated by interbreeding of HNF6 flox/flox mice with pdx1-Cre early transgenic mice (Gu et al., 2002) . pdx1-Cre early mediates recombination throughout the endogenous pdx1 domain: antral stomach, rostral duodenum, and entire pancreatic epithelium at e9.5 (Zhang et al., 2006) . In HNF6 flox/flox ; pdx1-Cre early (HNF6 Dpanc ) mice, Cre recombinase mediates the deletion of the entire cut-domain, generating a null allele (see Section 4 and Fig. 1A ). HNF6 Dpanc mice were born at the expected frequency and survived past weaning. In control pancreatic buds at e11.5, HNF6 was detected in all Pdx1-positive cells (Fig. 1Ba ), but the majority of Pdx1-positive cells were HNF6 negative in HNF6 Dpanc animals (Fig. 1Bb) . By e13.5, HNF6 protein was no longer detectable in HNF6
Dpanc pancreata ( Fig. 1Bd) , whereas expression in the control animals was as expected throughout the branching pancreatic epithelium (Fig. 1Bc) . No alteration in HNF6 protein expression was detected in HNF6 flox/+ ; pdx1-Cre early animals (data not shown). Previous in situ hybridization analysis showed that HNF6 is broadly expressed in the pancreatic epithelium during early organogenesis, but becomes restricted to ductal and acinar cells prior to birth (Landry et al., 1997; Rausa et al., 1997) . However, temporal regulation of HNF6 protein has not yet been addressed in detail. Upon examining HNF6 protein localization in the developing pancreas, nuclear-localized HNF6 was detected within the pancreatic epithelium at e15.5 ( Fig. 2A) , consistent with previous reports (Maestro et al., 2003; Pierreux et al., 2006) . The central epithelium at this stage has been suggested to be the location of pancreatic multipotent progenitors, (Fujitani et al., 2006; Zhou et al., 2007) , although recent results suggest that cells within the ductal trunk region give rise to endocrine and ductal cells, while those at the tip retain multipotency until late-gestation at which time they give rise to acinar cells (Zhou et al., 2007) . A large percentage of Ngn3-expressing cells within the trunk region co-expressed high levels of HNF6 ( Fig. 2A ) at e13.5 (69.1 ± 2.7%; 293 Ngn3-positive cells) and e15.5 (57.1 ± 2.4%; 789 Ngn3-positive cells). HNF6 was undetectable in either glucagon-or insulin-expressing cells in embryonic pancreata at e13.5 (data not shown), e15.5 ( Fig. 2B and C) or postnatal day (P) 1 (Fig. 2E and F ). Lower levels of nuclear HNF6 were detectable at distal ductal regions and in acinar cells at e15.5 (Fig. 2D) ; high levels were maintained in the ductal epithelium at P1 (Fig. 2E and F) . These latter data are consistent with previous reports demonstrating expression of HNF6 in ducts and 
2.2.
Inactivation of HNF6 throughout the early pancreas results in defects in epithelial branching and outgrowth
The embryonic phenotype of HNF6 Dpanc pancreata, while having some similarities to global HNF6 null mice (Jacquemin et al., 2000) also exhibited distinct differences. Consistent with the global HNF6 knockout, at e14.5 the epithelium of HNF6 Dpanc pancreata displayed less branching (compare Fig. 3A and B) and failed to fully extend toward the distal surrounding mesenchyme compared with controls. The mutant pancreatic epithelium never fully filled the mesenchyme postnatally (data not shown), suggesting that e14.5 HNF6 Dpanc pancreata were not simply developmentally delayed in their distal outgrowth. We observed a dramatic decrease in Ngn3-positive cells in HNF6 Dpanc pancreata at e13.5 (Fig. 3D ) similar to what was reported for HNF6 À/À mice (Jacquemin et al., 2000) . Previous studies indicated that the number of glucagon-expressing cells was reduced by 85% in HNF6 À/À embryos at e12.5 and e15.5, although the total number of a cell clusters was not different in the mutants (Jacquemin et al., 2000) . We did not observe any reduction in glucagon-positive cell clusters at e13.5 or e14.5 ( Figs. 1B and 3B and D) , although the number of a and b cells was reduced at e18.5 (data not shown). The dramatic reduction in endocrine cell number resulted in elevated blood glucose levels in HNF6 Dpanc mice at P2 and 3.5 weeks of age (Supplemental Fig. 1 ). No phenotypic differences were observed between males and females. At six weeks of age, random blood glucose levels in some HNF6 Dpanc mice were greater than 500 mg/dl (the limit of detection of the glucometer), so fasting glucose concentrations were examined instead. HNF6 Dpanc mice displayed a significantly higher fasting blood glucose level than controls (Supplemental Fig. 1 ). Thus, HNF6 Dpanc mice show impaired glucose homeostasis soon after birth and this worsens with age.
2.3.
Loss of HNF6 in Ngn3-expressing cells has no effect on b cell terminal differentiation
The expression data described above provides support for a model wherein HNF6 is required only early in development to initiate the endocrine program (via activation of Ngn3), but is not necessary for further steps of maturation or terminal differentiation. To directly test this hypothesis, we conditionally inactivated HNF6 in cells that had entered the pro-endocrine lineage using Ngn3Cre BAC (Schonhoff et al., 2004) . The pattern of recombination mediated by this Cre transgene recapitulates endogenous Ngn3 expression in both the endocrine pancreas and the enteroendocrine cells of the intestine, with minimal (>1%) non-endocrine recombination. Using the R26R reporter strain (Soriano, 1999) , we detected recombination [as visualized by X-gal staining to detect b-galactosidase (b-gal)] in developing endocrine clusters at e15.5 and a subset of cells within the endocrine cords ( Fig. 4A and B). b-gal-positive cells were detected as early as e13.5 ( Fig. 4C ) and by e15.5, nearly every Ngn3-positive cell expressed b-gal (Fig. 4D ). Many b-gal-positive cells did not express Ngn3, most likely due to the fact that these cells had already begun to differentiate and were no longer expressing Ngn3, which is not expressed in hormone-positive cells . These data indicate that the Ngn3Cre BAC transgene is able to direct cellspecific recombination early and efficiently within the developing pancreas. Because Ngn3 + /HNF6 + cells are a transitory population, we were concerned that the Ngn3Cre BAC transgene might not mediate recombination of the HNF6 flox allele early enough to produce an effect on the endocrine lineage. Ngn3 expression begins at e9.5 and reaches a peak at around e15.5 Jensen et al., 2000; Schwitzgebel et al., 2000) . We find a significant proportion ($70%) of Ngn3-expressing cells co-express HNF6 at e13.5. Analysis of HNF6 and b-gal expression at e13.5 ( Fig mental Fig. 2 ). To further assess b cell differentiation, we analyzed expression of Pdx1, MafA, and the glucose transporter GLUT2 (Supplemental Fig. 2 ). Localization of each of these proteins was comparable to controls. b cell function was assessed in vivo by performing IP-GTT at eight weeks of age. Fasting blood glucose, plasma insulin levels, and glucose tolerance profiles were indistinguishable between control and HNF6 Dendo animals (data not shown). In addition, total pancreatic insulin content at either P1 or eight weeks of age was similar between HNF6 Dendo and control animals (data not shown). Taken together, these data indicate that inactivation of HNF6 specifically in cells presumed to be committed to the endocrine lineage does not prevent b cell terminal differentiation or impair b cell function. BAC ; R26R (control) e15.5 pancreas in whole mount (A) and cross-section (B) stained with X-gal to detect recombination and counter-stained with eosin. White line in A delineates dorsal pancreas. X-gal staining was detected in cells in the endocrine cords (arrows) and in endocrine clusters that have migrated away from the cords (arrowheads). Recombination was detected in control pancreata as early as e13.5 (C) by co-localization of b-gal (red) with Ngn3 (green) on confocal 1 lm optical sections; by e15.5 (D), recombination had occurred in nearly all Ngn3 + cells. Co-localization of b-gal (red) and HNF6 (green) at e13.5
indicated that the majority of cells had lost HNF6 protein in HNF6 Dendo pancreata (F) as compared to wild type (E). Arrows indicate co-expression of b-gal and HNF6. li, liver; st, stomach; sp, spleen; int, intestine; dp, dorsal pancreas; ki, kidney. Scale bars represent 10 lm (A and B) or 20 lm (C-F).
2.4.
Sustained HNF6 is necessary to allocate appropriate numbers of progenitor cells to the endocrine lineage Morphometric analyses of P2 pancreata revealed a small, but statistically significant decrease in total endocrine area in HNF6
Dendo pancreata as determined by synaptophysin immunohistochemistry (Fig. 5 ) as compared to age-matched controls. This difference did not negatively impact glucose homeostasis even when mice were placed on a high fat diet to induce peripheral insulin resistance (data not shown). Morphometric examination of the lineage label ( Fig. 5B-E) revealed that the number of non-endocrine b-gal-expressing cells in HNF6 Dendo pancreata was increased over controls.
Recombination in Ngn3Cre BAC
; R26R mice was previously reported in a small percentage of acinar (0.5-1.8%) or ductal (1-5%) cells (Schonhoff et al., 2004) . Similarly, at P2 we observed that 2.48 ± 0.6% of X-gal-expressing cells are nonendocrine in control mice (n = 5; HNF6 (Fig. 6C) . Although, the large cyst was mainly located in the dorsal pancreas, dilated ductal epithelium was observed throughout the whole pancreas. Only a small were found abnormally within the multilayered epithelium. H&E staining of HNF6 Dpanc pancreata suggested acinar-to-ductal metaplasia (F, arrows). Cytokeratin labeling also revealed regions of squamous cell metaplasia in HNF6 Dpanc pancreata (G, arrows). dp: dorsal pancreas, int: intestine, sp: spleen, st: stomach, vp: ventral pancreas. Scale bars: in A, 100 mm for A and B; in F, 20 mm for D-F; in G, 20 mm.
portion of acinar tissue was detectable in mutant animals in close association with the cystic epithelium, whereas animals lacking cysts displayed only a minimally branched dorsal pancreas (data not shown) and/or possessed twisted irregular ducts and calcifications (data not shown). The epithelium of the dilated ducts in HNF6 Dpanc pancreata was multilayered ( Fig. 6E and G) , in contrast to the simple cuboidal to lowcolumnar epithelium of normal pancreatic ducts (Fig. 6D ). Glucagon-(data not shown), insulin- (Fig. 6E) , or Pdx1-positive cells (data not shown) were detected within the multilayered controls. Protein levels were normalized to b-actin using densitometry. Western blot also revealed a significant increase in p8 in HNF6 Dpanc pancreata, with very little p8 expression observed in control pancreata (G). Scale bar: in A, 20 mm for A-F.
epithelium of HNF6
Dpanc pancreata, however no definitive islets were observed. To examine whether the multilayered epithelium in HNF6 Dpanc mice was actively proliferating, BrdU was injected 6 h before mice were sacrificed. Anti-pan cytokeratin antibody was used to label ductal epithelial cells. A significant increase in ductal cell proliferation was observed in HNF6 Dpanc mice both at e17.5 (control, n = 4: 4.02% versus HNF6 Dpanc , n = 4: 7.79%, p 6 0.01) and six weeks of age (control, n = 5: 0.81% versus HNF6 Dpanc , n = 4: 4.66%, p 6 0.01).
Morphological and molecular characteristics of pancreatitis in HNF6
Dpanc animals
Acinar-to-ductal metaplasia was observed in all HNF6 Dpanc mice as early as P2 (Fig. 6F) . Squamous cell metaplasia was also observed in the ductal epithelium (Fig. 6G ). All HNF6 Dpanc pancreata (from 3 to 6 weeks of age) displayed morphological characteristics of pancreatitis, including profound atrophy, loss of acinar tissue, and acinar inflammation that was mostly lymphocytic (Fig. 7B ). Pancreatic ducts were highly tortuous (Supplemental Fig. 3 ), containing secretions, hemosiderin-laden macrophages, and neutrophils in the lumen (Fig. 7c and data not shown). The dilated ducts displayed periductal inflammation ( Fig. 7B and C) , hemorrhage ( Fig. 7D) and fibrosis (Fig. 7F) . Dystrophic calcifications were present in adjacent fat (Supplemental Fig. 3 ), indicative of previous fat necrosis. Some HNF6 Dpanc mice displayed additional characteristics of pancreatitis including (data not shown): neutrophils in peripancreatic fat; neutrophils in the lumen and ductal epithelium of smaller ducts; intraparenchymal mixed inflammatory infiltrate with neutrophils and lymphocytes, with areas of acinar injury; neutrophils scattered in periductal stroma; large ducts with erosion and acute inflammation. Previous studies have shown a 4.5-fold increase in expression of the secreted protein, CTGF, in human chronic pancreatitis (di Mola et al., 1999) . CTGF is involved in several fibrotic diseases and plays a critical role in fibrogenesis and tissue remodeling after injury (di Mola et al., 2002) . A recently identified gene, p8/(nuclear protein 1; Nupr1), is also up-regulated in human pancreatitis but is barely detectable in normal pancreata (Mallo et al., 1997) . p8/Nupr1 is induced in acinar cells during the onset of chronic pancreatitis as part of the selfdefense mechanism against proapoptotic insults (Motoo et al., 2001) , and is also up-regulated in acute pancreatitis (Mallo et al., 1997) . In addition, matrix metalloproteinase-7 (MMP7, matrilysin), a member of the MMP family of zincdependent extracellular proteases is associated with acinarto-ductal metaplasia and pancreatitis (Crawford et al., 2002) . Since HNF6 Dpanc mice showed pancreatitis and fibrosis surrounding the ducts, we examined CTGF expression in HNF6 Dpanc and control mice. Immunohistochemistry revealed very low levels of CTGF expression in the ducts of normal adult pancreata with a significant increase in CTGF expression in the ducts of HNF6 Dpanc animals (Supplemental Fig. 4 ).
Western blot analysis of total pancreatic protein extract confirmed that HNF6 Dpanc pancreata displayed a 2.8-fold increase in both CTGF and MMP7 ( Fig. 7G and H) . We also observed a significant increase in p8 in HNF6 Dpanc pancreata, with very little p8 expression observed in controls as expected (Fig. 7G) .
HNF6 Dpanc mice exhibited defects in primary cilia and decreased Prox1 expression
The primary cilia in the pancreatic ducts are immotile and have been proposed to function as chemo-or mechano-sensors (Davenport and Yoder, 2005) . A connection between cilia defects and pancreatitis is suggested by the fact that lesions reminiscent of pancreatitis are found in approximately 10% of patients suffering from the dominant form of polycystic kidney disease (Bas ßar et al., 2006) , and the absence of pancreatic cilia in mice results in lesions that resemble those found in patients with pancreatitis or cystic fibrosis (Cano et al., 2006) . Using antibodies against either b-tubulin or Arl13b (Caspary et al., 2007) , primary cilia that protruded into the ductal lumen were detected in control embryonic (Supplemental Fig. 5 ) and adult pancreatic duct epithelia (data not shown). In HNF6 Dpanc animals, cilia were detectable in ducts displaying a normal morphology at e18.5 (Supplemental Fig. 5C and D), although these were fewer in number and did not protrude into the duct lumen. However, dilated ducts in HNF6 Dpanc pancreata showed a dramatic decrease in cilia number at e18.5 (Supplemental Fig. 5E and F) and six weeks (data not shown).
The divergent homeodomain transcription factor Prox1 is a crucial regulator of mouse pancreas organogenesis (Wang et al., 2005) . Prox1 is expressed in nearly all pancreatic progenitor cells early in development but becomes restricted to islets and ducts at late-gestation (Wang et al., 2005) . Pancreas-wide inactivation of Prox1 also results in dilated pancreatic ducts and acinar-to-ductal metaplasia, similar to the phenotype observed in HNF6 Dpanc mice, however there is no change in HNF6 expression in embryos lacking pancreatic Prox1 (Dr. Beatriz Sosa-Pineda, personal communication). Thus, we hypothesized that HNF6 might act upstream of Prox1. At e18.5, Prox1 is highly expressed in pancreatic ducts in the control animals ( Fig. 8A and B) . The number of Prox1-positive cells was significantly reduced in HNF6 Dpanc pancreata ( Fig. 8C and D) .
Discussion
Precedent exists in the pancreas for transcription factors to have multiple functions at different developmental time points. For example, Pdx1 controls early steps of pancreatic bud outgrowth and proliferation (Jonsson et al., 1994; Offield et al., 1996) , but it also regulates later steps of acinar cell differentiation (Hale et al., 2005) , embryonic b cell proliferation , and b cell function (Ahlgren et al., 1998; Holland et al., 2002) as its expression becomes gradually down-regulated in the pancreatic epithelium and enhanced in b cells.
The present study addresses the specific consequences of HNF6 inactivation in early pancreatic buds or committed endocrine cells on both pancreas development and postnatal pancreas function. The present study confirms that HNF6 plays an essential role in both endocrine and duct development, and is the first to demonstrate that loss of HNF6 activity can induce pancreatitis and cellular changes associated with pancreatic neoplasia.
3.1.
Comparison of HNF6 mutant phenotypes reveals similarities and differences
Although the number of glucagon-positive cells appeared unchanged at e14.5 in HNF6
Dpanc embryos, we did observe a decrease in Ngn3 expression in HNF6 Dpanc at e14.5, and a subsequent reduction in the number of insulin-and glucagon-positive cells, at e18.5 and P2, similar to what was reported for HNF6 À/À null animals at early postnatal stages. Thus, in both models, the reduction in endocrine cells is most likely due to the reduction in the number of Ngn3-expressing cells. A difference between HNF6 À/À and HNF6 Dpanc animals was observed in early postnatal glucose homeostasis. Previous analysis of HNF6 À/À neonates revealed decreased plasma glucose at P4 (Jacquemin et al., 2000) ; however, HNF6 Dpanc animals showed significantly elevated glucose levels at P2. HNF6 is highly expressed in the liver, and previous studies have shown that HNF6 stimulates transcription of both glucokinase (Lannoy et al., 2002 ) and glucose-6-phosphatase in the liver (Streeper et al., 2001 ). The observed hypoglycemia in HNF6 null neonates could be caused by loss of HNF6 in the liver resulting in defects in glycogen storage, glycogenolysis or gluconeogenesis. The early hyperglycemia observed in HNF6
Dpanc neonates is revealed in the absence of the confounding effects from loss of HNF6 in the liver.
In the original description of the HNF6 À/À phenotype, islets were observed in the animals that survived the neonatal period and lived to adulthood, but these islets had a disrupted architecture and impaired function (Jacquemin et al., 2000) . In contrast, HNF6 Dpanc adult pancreata contained individual insulin-positive cells or small endocrine clusters of less than 8 cells, but no definitive islets. The cause of this discrepancy is currently unclear, but may be due to the difference in genetic background of the mice used in the two studies.
Ductal defects in HNF6
Dpanc
animals include pancreatitis and metaplasia
The vast majority of HNF6 global null animals die between P1 and P10 (Jacquemin et al., 2000) . Restriction of HNF6 inactivation to the pdx1-expression domain using Cre-lox technology permitted an analysis of HNF6 function in all mutant animals after birth. Although cystic structures were observed in pancreata of HNF6 null animals (Jacquemin et al., 2000) , this is the first study in which pancreatitis has been described due to HNF6 inactivation in the pancreas.
CTGF exhibits a diverse range of cellular functions including cell adhesion, cell migration, potentiation of growth factor-induced proliferation, inflammation, fibrosis, tumor growth, and tumor metastasis (Dornhofer et al., 2006) . Its expression strongly correlates with increased pancreatic fibrosis (di Mola et al., 1999) . Thus, the fibrosis observed in HNF6 Dpanc pancreata may be caused by increased CTGF. Interestingly, we have found that over-expression of HNF6 in the developing pancreas leads to a decrease in CTGF expression (Wilding Crawford et al., 2008) . Taken together, our results suggest that HNF6 negatively regulates CTGF expression, although it is currently unknown whether this is due to direct binding of HNF6 to the CTGF promoter. The increase in p8 observed in HNF6 Dpanc pancreata further supports the development of pancreatitis in these animals. p8/Nupr1 is a transcriptional cofactor expressed at only low levels in normal pancreata but is induced in the initial phases of pancreatitis and is associated with acinar regeneration and proliferation (Mallo et al., 1997) , and more recently, b cell proliferation (Yanagita et al., 2006) . Thus, induction of p8 expression in HNF6 Dpanc pancreata may be indicative of mutant acinar cells mounting a protective response to cellular stress (Motoo et al., 2001) , and/or stimulate proliferation of acinar cells and the few b cells present. Although bile duct blockage is known to be a cause of pancreatitis in humans, and HNF6 is deleted from the common bile duct in our model (data not shown), we do not believe that loss of HNF6 from the bile duct is the cause of the observed pancreatitis. The bile ducts from HNF6
Dpanc animals were slightly smaller, but were not distended or blocked (data not shown). Instead, we hypothesize that the defects in primary cilia are the main cause for the ductal cysts and metaplasia present in HNF6 Dpanc pancreata. Primary cilia are found on most vertebrate epithelial cells and play a negative role in epithelial cell proliferation (Pugacheva et al., 2007) by acting as chemo-or mechano-sensors particularly in liver, kidney and pancreas (Davenport and Yoder, 2005) . Primary cilia function is required for the maturation and maintenance of proper tissue organization in the pancreas (Cano et al., 2004) : reductions in cilia in the Oak Ridge polycystic kidney (orpk) mutant mouse results in abnormal tubular structures and massive acinar cell loss, similar to what we observed in HNF6 Dpanc pancreata. Cysts were also observed in HNF6 À/À embryos, and were associated with abnormal development of primary cilia in duct cells and reduced expression of genes involved in polycystic disease, namely those encoding HNF-1b and cilium-associated proteins polyductin, fibrocystin, and cystin (Pierreux et al., 2006) . The homeobox-containing transcription factor Prox1, the mammalian homologue of the Drosophila gene prospero, is expressed in nearly all pancreatic progenitor cells early in development (Wang et al., 2005) . Our immunohistochemical analyses suggest that HNF6 functions upstream of Prox1, and may regulate pancreatic duct morphogenesis in part through Prox1.
Both acinar-to-ductal and squamous cell metaplasia were observed in HNF6
Dpanc pancreata. Patients with ductal metaplasia arising in the setting of chronic pancreatitis have a 16-fold increase in relative risk for pancreatic ductal adenocarcinoma (PDAC) (Lowenfels et al., 2000) . MMP7 is expressed in the epithelium of pre-malignant lesions in multiple glandular tissues, including breast, prostate, and intestine (Powell et al., 1996) and is thought to influence the initiation and maintenance of metaplastic events in the pancreatic epithelium (Crawford et al., 2002) . We detected elevated MMP7 levels in HNF6 Dpanc animals. In addition, elevated CTGF levels have been detected in PDAC, and inhibition of CTGF with a human monoclonal antibody has been shown to reduce primary and metastatic tumor growth in a mouse model of PDAC (Dornhofer et al., 2006) . Thus, taken together, these results suggest that loss of HNF6 in the pancreas may cause increased risk of PDAC or more rare forms of pancreatic cancer such as squamous cell carcinoma.
Maintained HNF6 is required to ensure proper allocation of progenitors to the endocrine lineage
We found that b cell terminal differentiation proceeds normally in cells that have lost HNF6 subsequent to activation of the Ngn3 promoter. These results are consistent with the protein expression pattern of HNF6, wherein HNF6 appears to be rapidly down-regulated from Ngn3-expressing cells as they are specified to the endocrine lineage. These data strongly support the hypothesis that HNF6 is not necessary at subsequent steps of endocrine differentiation, but functions specifically at the initial steps of endocrine specification. Indeed, our previous studies showing that maintenance of HNF6 in the endocrine lineage is incompatible with proper b cell differentiation and function (Gannon et al., 2000; Tweedie et al., 2006 ) also support this model of HNF6 activity in the pancreas.
Altered allocation of Ngn3-expressing cells to non-endocrine lineages in HNF6
Dendo pancreata suggests that Ngn3-expressing cells retain some degree of plasticity during the initial stages of lineage commitment. Pro-endocrine progenitors in HNF6 Dendo mice are exposed to a reduced duration of HNF6/Ngn3 co-expression and thus a reduced number of cells that have activated Ngn3 remain committed to the endocrine lineage. This suggests that a threshold level of Ngn3 must be attained to irreversibly commit cells to an endocrine fate. Our data are consistent with a recent study in which Ngn3 expression was induced during specific developmental time windows in the context of the Ngn3 null background (Johansson et al., 2007) . The authors suggest that the pancreatic epithelium responds in a cellautonomous manner to threshold levels of Ngn3 that determine the number of cells shunted into the endocrine pathway. Thus, HNF6 may be necessary to maintain sufficient levels of Ngn3 within presumptive endocrine progenitors, such that they are ensured of an endocrine fate. That HNF6 is rapidly down-regulated in committed endocrine cells also suggests that some signal, specific to the endocrine cell lineage, is involved in silencing HNF6. Further studies identifying an HNF6 repressor will be necessary to confirm or disprove this hypothesis.
Experimental procedures
4.1.
Generation of mice
To generate mice with a loxP-containing HNF6 allele (HNF6 flox ), we constructed a loxP-FRT HNF6 flox-neo targeting vector using BAC recombineering (Liu et al., 2003) . To avoid disrupting potential regulatory regions within the HNF6 locus, mouse and human HNF6 gene homology was compared (using http://genome.ucsc.edu) and loxP sites introduced flanking the cut-domain in regions of less than 50% sequence conservation (Fig. 1A) (Hogan et al., 1994) . ES cell colonies containing the HNF6 flox-neo targeted allele were determined by Southern blot analysis with 5 0 and 3 0 external probes (Fig. 1A , Supplemental   Fig. 6 ). Using a 5 0 genomic probe and SpeI/EcoRV digestion, the HNF6 flox allele was detected as a smaller molecular weight DNA fragment because of the EcoRV site engineered 1.7 kb upstream of the endogenous EcoRV site (Supplemental Fig. 6A ). Using a 3 0 genomic probe and SacII/HpaI digestion (Fig. 1A) , the HNF6 flox allele was detected as a larger band due to the 2 kb PGK-neo R positive selection cassette (Supplemental . These primers amplify a 550 bp band in the endogenous allele and a 590 bp band in the floxed allele (Supplemental Fig. 6B ). Two Cre driver lines were used for these studies. The presence of each Cre transgene was determined by PCR using primers for Cre (Zhang et al., 2006) . In the pdx1-Cre early line, 5.5 kb of the pdx1 5 0 regulatory region drive early pancreaswide Cre expression (Gu et al., 2002) . HNF6 flox/flox ; pdx1-Cre (HNF6 Dpanc ) mice were sacrificed by three months of age, due to severe diabetes and large pancreatic cysts. The Ngn3Cre BAC transgene is comprised of a bacterial artificial chromosome (BAC) spanning approximately 180 kb of the Ngn3 locus, with a nuclear-localized Cre recombinase inserted into the translational start site of Ngn3 (Schonhoff et al., 2004) . Recombination was monitored using the ROSA26 (R26R) reporter strain (Soriano, 1999 ).
An inbred hybrid line (B6D2; Jackson Labs) was used for endogenous HNF6 protein expression studies. For embryonic analyses, the morning of the vaginal plug was considered e0.5. Mice were maintained on mouse chow 5015 (24% fat, 57% carbohydrates, 19% protein; TestDiet) ad libitum. All mouse studies were performed in accordance with the Vanderbilt Institutional Animal Care and Use Committee guidelines under the supervision of the Division of Animal Care.
Histology and immunolabeling
Dissected tissues were fixed (4% paraformaldehyde, 4°C, 2 h), dehydrated in an ethanol series, embedded in paraffin, and sectioned to a thickness of 5 lm. Tissues for cryosectioning were fixed overnight at 4°C, incubated in 30% sucrose overnight at 4°C, embedded in OCT compound (VWR Scientific, West Chester, PA), and 5 lm sections were cut on a Leica CM 3050 S cryostat.
Paraffin sections were deparaffinized in Citrisolv (Fisher) and rehydrated in a decreasing ethanol series to distilled water. Hematoxylin and eosin (H&E) staining was as described (Offield et al., 1996) . Masson trichrome staining was performed following the manufacturer's instruction (Sigma). Primary antibodies were used at the following dilutions: guinea-pig anti-insulin (1/1000, Linco), rabbit anti-glucagon (1/ 1000, Linco), rabbit anti-MafA (1/500, Calbiochem), rabbit anti-GLUT2 (1/500, a gift of Bernard Thorens, Univ. of Lausanne), guinea-pig anti-Pdx1 (1/1000, a gift of Chris Wright, Vanderbilt Univ.), mouse anti-synaptophysin (1/500, Chemicon), guinea-pig anti-Ngn3 (1/1000, a gift from Dr. Maike Sander, Univ. of California at Irvine), rat anti-BrdU (1/400, Accurate Chem Scientific Corp.), rabbit anti-CTGF (1/1000, a gift from Dr. David Brigstock, The Ohio State Univ.), rabbit anti-cytokeratin (1/1000, Dako), mouse anti-acetylated btubulin (1/5000, Sigma), rabbit anti-Arl13b/Hennin (1/500, a gift from Dr. Tamara Caspary, Emory University), rabbit antiProx1 (1/500, Angiobio Co.). Detection of MafA required Tris/ EGTA antigen retrieval, detection of Pdx1 and GLUT2 required sodium citrate antigen retrieval as previously described (Tweedie et al., 2006) ; detection of cytokeratin and Arl13b/ Hennin required antigen retrieval with proteinase-K diluted 1:1000 (Dako) for 5 min prior to primary antibody.
Frozen sections were thawed to room temperature and permeabilized in 0.1% Triton in PBS for 45 min. Primary antibodies were used at the following dilutions: rabbit anti-HNF6 (1/250, Santa Cruz Biotechnology, Inc.), guinea-pig anti-Ngn3 (1/1000), rabbit anti-b-gal (1/5000, MP Biomedicals), rabbit anti-amylase (1/500, a gift of Ray MacDonald, Univ. of Texas Southwestern), and anti-insulin and anti-glucagon (as above). All primary antibodies were incubated overnight at 4°C in a humidified chamber. Primary antibodies were detected by species-specific donkey secondary antibodies conjugated with Cy2, Cy3, or Cy5 fluorophores (1/500, Jackson Immunoresearch).
Where indicated, a Zeiss LSM 510 confocal microscope was used to visualize 1 lm optical sections on immunofluorescently labeled tissue. Other samples were viewed under bright-field illumination or appropriate optical filters (immunofluorescence) using an Olympus BX41 microscope and digital camera with the Magnafire program (Optronics, Inc.). Whole-mount samples were viewed using an Olympus SZX9 dissecting microscope and photographed using a Nikon CoolPix 4300 digital camera. TIFF images from each experiment were processed equivalently for brightness and contrast in Adobe Photoshop.
b-Gal activity was detected using X-gal as previously described (Wu et al., 1997) . Following fixation, pancreata were washed two times for 30 min each in permeabilization solu-tion. Samples were incubated overnight at room temperature in staining solution, post-fixed in 4% paraformaldehyde in PBS at 4°C for one hour, and dehydrated as above, substituting isopropanol for xylene to minimize leaching of the precipitate. Sections were counter-stained with eosin (Surgipath) for contrast.
4.3.
Morphometric analysis
Endocrine area
Sections of perinatal pancreata were immunolabeled at 250 lm intervals along the length of the pancreas (at least seven sections per pancreas) for synaptophysin, a pan-endocrine marker. Total pancreatic area (identified by eosin counter-stain) was quantitated using Metamorph software (Molecular Devices). Total endocrine area was determined by manual demarcation of synaptophysin-positive cells. Average endocrine area was expressed as a percentage of total pancreatic area measured.
Recombined area
Sections of X-gal stained pancreata were quantitated for total pancreatic area as described above. Total recombined area was quantitated by setting an RGB threshold that would cover the X-gal-positive area. Following manual demarcation of X-gal-positive islet-like clusters, endocrine area was subtracted from the total recombined area to quantitate the non-endocrine recombined area. The average non-endocrine recombined area was expressed as a percentage of total pancreatic area measured.
All statistical analyses were performed by two-tailed Student's t-test using Excel software.
Protein extraction and western blotting
Adult pancreata were dissected and immediately placed into extraction buffer containing a protease inhibitor cocktail (0.5 mg/L TPCK, 0.5 mg/L TLCK, 0.6 lM leupeptin, and 2 lM pepstatin), DTT, and PMSF. Samples were homogenized, centrifuged, and the supernatant was quantitated by the Bio-Rad DC protein assay according to manufacturer's instructions.
Protein was electrophoresed on 4-20% Tris-glycine gels (Invitrogen) and blotted to PVDF membrane (Amersham Bioscience). Primary antibodies were incubated at 4°C overnight using the following dilutions: rabbit anti-CTGF (1/ 5000); rabbit anti-MMP7 (1/1000; a gift from Dr. Barbara Fingleton, Vanderbilt Univ.); rabbit anti-p8 (1/3500; (Path et al., 2004) ; rabbit anti-b-actin (1:5000; Santa Cruz Biotechnology, Inc.); and rabbit anti-CFTR (1/1000; ABR-Affinity BioReagents). HRP-conjugated species-specific secondary antibodies were diluted to 1/10,000 (anti-rabbit IgG, Santa Cruz) or 1/5000 (anti-rat IgG, Amersham) in 1% non-fat milk or 1% BSA in TBS and incubated for one hour at room temperature. Protein detection was facilitated by the ECL detection system (Amersham) following the manufacturer's instructions. Protein levels were quantitated on a Molecular Imager FX densitometer (Bio-Rad) using Quantity One 4.6 software (Bio-Rad) and normalized to b-actin, where control levels were assigned a value of 1.0.
Assessment of glucose homeostasis
Intraperitoneal glucose tolerance tests (IP-GTT) were performed on 8 week old mice as previously described (Tweedie et al., 2006) . Insulin secretion in response to a glucose challenge was assessed by collecting blood retro-orbitally at fasting (0 min) and 30 min following glucose injection. Insulin concentration in the plasma, as well as total pancreatic insulin extracted from early postnatal and adult pancreata (acid alcohol extracts) was quantitated by solid phase radioimmunoassay as previously described (Tweedie et al., 2006) .
Mice were weaned at three weeks of age and placed on high fat diet (58.7% fat, 26.7% carbohydrate, 14.8% protein, Bio-Serv) ad libitum for 8.5 weeks to induce peripheral insulin resistance. At 12 weeks of age, mice were subjected to IP-GTT and insulin secretion assays as described above.
